France1 robot tracked

Moon Surgical

Moon Surgical makes Maestro, which is at stage 5 of 5: regulator-cleared or mass market.

Website: moonsurgical.com
Based in: France
Latest milestone: 22 July 2026

01Robots

What Moon Surgical makes

Each robot's stage is worked out from its dated, sourced milestones by the same published rules, whoever the maker is.

MaestroMedical · Robotic surgical assistantStage 5 of 5 · Regulator-cleared or mass marketMaestro is a pair of robot arms that holds the camera and tools during keyhole (laparoscopic) surgery, so the surgeon needs fewer helpers in the room. An AI feature called ScoPilot lets the camera follow the surgeon's instrument.Used in US hospitals and outpatient surgery centers (for example Lee Health in Florida and Surgeon's Point Surgery Center in Texas) and in France.The full record

02Track record

Every dated event

22 July 2026Milestone
Moon Surgical and the surgical-equipment maker KARL STORZ agreed to sell and use their products together.
Moon Surgical press release, 22 July 2026Company-reported
2 July 2025Regulator
The FDA cleared two more Maestro features, including a wireless link to the company's cloud data service, Maestro Insights.
MassDevice, 2 July 2025Company-reported
July 2025Milestone
Moon Surgical said Maestro had been used in more than 1,600 operations worldwide, 1,400 of them in the past year, as Lee Health in Florida passed 100 cases.
Moon Surgical press release via Sofinnova, July 2025Company-reported
18 March 2025Regulator
The FDA cleared ScoPilot, an AI feature that makes the camera follow the tip of a chosen instrument (510(k) K242323).
MassDevice, 18 Mar 2025 (FDA record K242323)
9 Jan 2025Milestone
Surgeon's Point Surgery Center in Cedar Park, Texas became the first outpatient surgery center to use Maestro, with 20 patients treated.
Moon Surgical press release via Sofinnova, 9 Jan 2025Company-reported
26 Sept 2023Milestone
Baptist Health in Jacksonville, Florida did the first US operations with Maestro: weight-loss stomach surgeries.
MassDevice, 26 Sept 2023Company-reported
2 Dec 2022Regulator
The FDA cleared the first version of Maestro through the 510(k) route (K221410).
Fierce Biotech, 19 Dec 2022 (FDA record K221410)

03Money

How it's funded

Latest funding round we could confirm: Moon Surgical raised $55.4 million in a round led by Sofinnova Capital Strategy and NVentures, Nvidia's venture arm. Fierce Biotech, 17 May 2023

All robot stocks, funding and suppliers